These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10920850)

  • 1. [Experiences with the Port-A-Cath system in children].
    Wildhaber B; Kistler W; Caflisch U
    Schweiz Med Wochenschr; 2000 May; 130(20):732-8. PubMed ID: 10920850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Totally implantable central venous access devices in pediatric oncology--our experience in 46 patients.
    De Backer A; Vanhulle A; Otten J; Deconinck P
    Eur J Pediatr Surg; 1993 Apr; 3(2):101-6. PubMed ID: 8323914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with a modified implantation technique of Port-A-Cath systems as continuous venous access in infants and children].
    Erhard J; Lange R; Kremens B; Krause U; Eigler FW
    Med Klin (Munich); 1991 Oct; 86(10):512-4. PubMed ID: 1758373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children.
    Harvey WH; Pick TE; Reed K; Solenberger RI
    Surg Gynecol Obstet; 1989 Dec; 169(6):495-500. PubMed ID: 2683154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term experiences with central venous catheters in pediatric oncology].
    Hadjilaskari P; Brühmüller S; Fengler R; Hartmann R; Waldschmidt J; Henze G
    Monatsschr Kinderheilkd; 1990 Jan; 138(1):26-30. PubMed ID: 2107396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experiences with the Port-A-Cath system, a fully implantable central venous access system, in children].
    Hager J; Margreiter R; Ausserer B
    Z Kinderchir; 1987 Feb; 42(1):36-9. PubMed ID: 3551382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New implantable device for long-term vascular access in children.
    Reinberg O; Beck D
    Eur J Pediatr Surg; 1992 Jun; 2(3):183-5. PubMed ID: 1498114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Port-A-Cath infections in children with cancer.
    Hengartner H; Berger C; Nadal D; Niggli FK; Grotzer MA
    Eur J Cancer; 2004 Nov; 40(16):2452-8. PubMed ID: 15519519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Port-A-Cath insertions in acute leukemia: does thrombocytopenia affect morbidity?
    Loh AH; Chui CH
    J Pediatr Surg; 2007 Jul; 42(7):1180-4. PubMed ID: 17618877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness and indications for Port-a-Cath in children with acute leukemia].
    Parri FJ; Rovira J; Sancho MA; Julia V; Albert A; Morales L
    Cir Pediatr; 1989 Apr; 2(2):61-3. PubMed ID: 2485670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications of the use of implantable reservoirs of central venous access++ in pediatrics: causes and treatment].
    Pérez Martínez A; Martínez Ibáñez V; Ezzedine M
    Cir Pediatr; 1993 Apr; 6(2):59-62. PubMed ID: 8357723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
    Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
    J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with totally implantable venous access systems in pediatric hematology and oncology].
    Maloisel F; Geiss S; Clavert JM; Amaral D; Babin-Boilletot A
    Ann Pediatr (Paris); 1993 Jun; 40(6):353-9. PubMed ID: 8352496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
    Mancuso ME; Mannucci PM; Sartori A; Agliardi A; Santagostino E
    Br J Haematol; 2008 May; 141(5):689-95. PubMed ID: 18410458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
    Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
    Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
    Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
    Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.
    Komvilaisak P; Connolly B; Naqvi A; Blanchette V
    Haemophilia; 2006 Dec; 12 Suppl 6():87-93. PubMed ID: 17123400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of outcomes and survivals for two central venous access port systems.
    Hou SM; Wang PC; Sung YC; Lee HH; Liu HT; Chen YH
    J Surg Oncol; 2005 Jul; 91(1):61-6. PubMed ID: 15999349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a polymer implanted port access device.
    Brown JM
    J Intraven Nurs; 1996; 19(6):303-6. PubMed ID: 9060356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early and late complications after implantation of central venous catheters].
    Herold A; Rothe K; Woller T; Bierbach U; Bennek J
    Klin Padiatr; 2003; 215(1):24-9. PubMed ID: 12545422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.